Related Experiment Videos
Vasopressin receptors
1UCLA School of Medicine, Los Angeles, CA 90095-7115, USA. marielb@ucla.edu
Trends in Endocrinology and Metabolism: TEM
|November 25, 2000
Summary
Arginine vasopressin (AVP) affects the body through three receptors: V1a, V1b, and V2. Understanding these receptors clarifies conditions like diabetes insipidus and AVP's role in water balance.
Area of Science:
- Endocrinology
- Molecular Biology
- Nephrology
Background:
- Arginine vasopressin (AVP) mediates biological effects via V1a, V1b (Gq/11-coupled), and V2 (Gs-coupled) receptors.
- Receptor subtype identification is crucial for understanding AVP's diverse physiological roles.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying AVP receptor signaling.
- To correlate receptor subtype identification with disease pathologies like nephrogenic diabetes insipidus.
Main Methods:
- Isolation and characterization of complementary DNAs (cDNAs) encoding V1a, V1b, and V2 receptors.
- Analysis of receptor binding and signaling pathways (phospholipase activation, adenylyl cyclase stimulation).
Main Results:
- cDNA isolation explained tissue variability in V1 antagonist binding.
- V2 receptor cDNA and gene identification enabled pinpointing mutations causing X-linked nephrogenic diabetes insipidus.
- AVP's primary role in water homeostasis is highlighted by diabetes insipidus manifestations.
Conclusions:
- AVP receptor subtype characterization is key to understanding AVP's physiological functions.
- Genetic defects in AVP signaling lead to significant water balance disorders.
- AVP's role in blood pressure regulation remains less defined despite ongoing research.